One day before the experiment, HMC3 cells were harvested by using a trypsin-EDTA solution, counted with a C-Chip disposable hemocytometer, and plated in 96-well plates (8 × 103 cells/well). The following day, cells were treated with increasing concentrations of carnosine (1, 10, and 20 mM) and incubated for 24 h in a humidified environment (37 °C, 5% CO2). Cell viability was measured through the well-known 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) method [34]. Briefly, after the stimulation process, MTT solution (1 mg/mL in EMEM medium) was added to each well and cells were incubated (2 h, 37 °C). During the final step, dimethyl sulfoxide was used to melt the crystals, while the Synergy H1 Hybrid Multi-Mode Microplate Reader (Biotek, Shoreline, WA, USA) was used to read the absorbance at 569 nm. Data are the mean of four independent experiments (n = 4). Values were normalized with respect to control untreated HMC3 cells and are expressed as the percent variation of cell viability.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.